Banner

May 9, 2008

Wednesday News

GSK Endorses Insightful Stats Tool

News bulletins on Premier Research, Octagon Research, ChemDiv, Syndexa, Synexus, BR Pharma and Veeda Clinical.

Tuesday News

Phase Forward Revenues Jump

A few news bulletins about LCG Bioscience, Baird Private Equity, MPI Research, Diversity Allliance, Bayer, and M.D. Anderson. 

Monday News

Parexel Earnings

A few news bulletins on Echo Therapeutics, Theravance, PPD, Cryoport, Medidata and Parexel. 

Monday News

Industry Ignores Registry Rule

With bulletins about CRO oversight, reprint distribution, Encorium Group, PHT, MDS Pharma and Obrem Capital.

Friday News

i3 Buys Russian CRO

A few news bulletins on Oramed, Paradigm Management, i3, PPD, TrialStat and the German Merck.

thumbnail
Thursday News

iGuard: New Statin Concern

May 08, 2008

Commonwealth Biotechnologies is pleased to announce further details regarding Venturepharm Asia, its joint venture with Venturepharm Laboratories (VPL). The partnership was established to leverage CBI’s and VPL’s respective strengths in drug discovery and clinical research. The initial focus will be to establish two new state-of-the-art chemistry facilities in Jiangsu province,… more...

thumbnail
Wednesday News

Covance Award, ERT Earnings

May 07, 2008

etrials is in upheaval, with several executives coming and going. “etrials has been undergoing a series of rigorous Company-wide process improvement and reengineering initiatives designed to improve customer service, streamline internal processes, and at the same time reduce costs,” said president and CEO Chip Jennings. “In order to take full… more...

thumbnail
Monday News

United Biosource Buys Envision

May 05, 2008

Covance allowed a tour of a controversial Arizona lab for animal testing. “We always anticipate that there will be protests,” said Camilla Strongin, a spokeswoman for Covance’s public relations and lobbying firm, the Symington Group, chaired by former state governor Fife Symington. Here’s the story. NovaRx selected two elements of… more...

thumbnail
Friday News

PharmaNet Earnings, Cancellations

May 02, 2008

Industry titan Robert Ruffalo is stepping down from head of R&D at Wyeth. “"Bob Ruffolo has been the driving force of our R&D progress, establishing Wyeth as one of the research leaders in the pharmaceutical industry,” said Bernard Poussot, Wyeth’s president and CEO. “His legacy will be our pipeline, recognized… more...

thumbnail
Wednesday News

GSK Endorses Insightful Stats Tool

April 30, 2008

Veeda Clinical Research, a full service contract research organization, announced the launch of a global oncology CRO. Veeda Oncology aims to provide oncology clinical research services internationally. Said Binoy Gardi, group MD at Veeda Clinical Research: “Since July 1, 2007, we have been establishing the infrastructure for a global oncology… more...

thumbnail
Tuesday News

Phase Forward Revenues Jump

April 29, 2008

LCG Bioscience and the Harley Street Clinic are joining forces to provide sponsors with access to London clinical trials expertise, a diverse range of patient populations, major teaching hospital specialists and intensive care facilities outside the constraints of a National Health Service environment. LCG medical director Anthony Priestley says: “LCG… more...

thumbnail
Monday News

Parexel Earnings

April 28, 2008

Echo Therapeutics announced that it has signed a dermatology product and transdermal drug delivery technology right of first offer agreement with Cato BioVentures, the venture capital affiliate of Cato Research, a contract research and development organization. The agreement grants Echo exclusive rights of first negotiation to all dermatology product and… more...

more Bulletins stories...